Elephas Biosciences Corporation

Elephas Biosciences Corporation is listed as a new startup research supplier in the Scientist.com network, with 2 sites in 1 country.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 2

Countries 1

Type of company: New startup

Solid Tumor CDx Design and validate companion diagnostics for solid tumors that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.

Clinical Responder Analysis, Patient Stratification The process of identifying patients that are more likely to respond positively to a drug.
Translational Biomarker Discovery An approach to finding markers that change in response to a drug or that identify a group that responds favorably to a specific therapy. These can be omics, molecular, histologic, radiologic, etc.

Human Organoids Test immuno-oncology drugs and therapies on fresh, unpropagated 3D tumor organoids to evaluate efficacy and understand drug mechanism of action. Understand the intact tumor immune microenvironment, cytotoxic efficacy...

Organoid Screening Assay Evaluate the effects of various substances, such as drugs or genetic modifications, on organoids.

Ex-Vivo PDX Screening Ex-vivo PDX screening is used to evaluate the effectiveness of various drugs on tumor cells.

Work with Elephas Biosciences Corporation on Scientist.com

For prices, more details, or to contact Elephas Biosciences Corporation, visit Scientist.com.